ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 116 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $156,595 | -29.7% | 14,690 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $222,700 | +138.1% | 14,690 | +30.9% | 0.00% | +200.0% |
| Q1 2020 | $93,513 | -50.7% | 11,226 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $189,719 | -9.0% | 11,226 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $208,467 | -41.8% | 11,226 | -28.2% | 0.00% | -50.0% |
| Q2 2019 | $357,956 | +50.1% | 15,645 | +37.9% | 0.00% | +33.3% |
| Q1 2019 | $238,535 | +82.8% | 11,348 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $130,502 | -49.9% | 11,348 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $260,437 | +2.9% | 11,348 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $253,000 | -2.3% | 11,348 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $259,000 | -12.8% | 11,348 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $297,000 | – | 11,348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,067,560 | $53,364,000 | 28.19% |
| Selkirk Management LLC | 208,000 | $5,368,000 | 2.94% |
| Iguana Healthcare Management, LLC | 270,000 | $6,969,000 | 2.20% |
| Opaleye Management Inc. | 100,600 | $2,596,000 | 1.03% |
| Miura Global Management | 600,000 | $15,486,000 | 0.94% |
| DSC Advisors, L.P. | 57,400 | $1,481,000 | 0.77% |
| Cannell & Co. | 1,016,828 | $26,244,000 | 0.74% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $7,138,000 | 0.61% |
| Harvest Capital Strategies LLC | 100,000 | $2,581,000 | 0.33% |
| Raging Capital Management, LLC | 93,932 | $2,424,000 | 0.31% |